Lorenzen S, Knorrenschild JR, Pauligk C, Hegewisch-Becker S, et al. Phase III randomized, double-blind study of paclitaxel with and without everolimus in patients with advanced gastric or esophagogastric junction carcinoma who have progressed after therapy with a fluoropyrimidine/platinum-containing regimen (RADPAC). Int J Cancer 2020;147:2493-2502.
PMID: 32339253